Susan G. Komen helps people with any stage of breast cancer find and participate in clinical trials, including trials supported by Komen.
Meet Sandi Spivey, initially diagnosed with breast cancer
in 1995 and with metastatic breast cancer in 1998, as she
talks about her personal experience with clinical trials.
They only way this happens is through clinical trials. These trials are the oncology ‘‘village’’ at its best: brilliant researchers creating new therapeutic or diagnostic approaches to target breast cancer, doctors designing the best trials to test these agents, courageous patients willing to give that most precious of commodities, themselves, for the common good.’’
People who join clinical trials receive high-quality care,
and at the same time are contributing to research that
could help themselves or others.
People who join clinical trials help further the knowledge base that ultimately helps improve breast cancer care.
The Breast Cancer Weight Loss (BWEL) trial aims to study whether a structured weight loss program could reduce the risk of breast cancer recurrence in women
with breast cancer. The results of this study could potentially improve outcomes in hundreds of thousands of women with breast
cancer around the world and support Komen’s Bold Goal of reducing breast cancer deaths by 50% in the U.S. by 2026.
If you or a loved one needs information or resources about
clinical trials, call our Clinical Trial Information
Helpline at 1-877 GO KOMEN (1-877- 465- 6636) or email
Call our Clinical Trial Information Helpline to speak with a
or email at
The Helpline offers breast cancer clinical trial education and
support, such as:
Breast cancer patients at any stage can join a clinical trial.
Breast cancer clinical trials study prevention, new screening
tests and treatment options, as well as quality of life issues.